Targeting STING pathways for the treatment of cancer

Claudia Gravekamp, Dinesh Chandra

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.

Original languageEnglish (US)
Issue number12
StatePublished - Dec 2 2015


  • IL-12
  • Listeria-Mage-b
  • STING ligand
  • c-di-GMP
  • metastatic breast cancer

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology


Dive into the research topics of 'Targeting STING pathways for the treatment of cancer'. Together they form a unique fingerprint.

Cite this